Ameriprise’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-74,853
Closed -$109K 3975
2022
Q3
$109K Buy
+74,853
New +$109K ﹤0.01% 3806
2018
Q3
Sell
-51,852
Closed -$1.19M 3727
2018
Q2
$1.19M Sell
51,852
-941
-2% -$21.5K ﹤0.01% 2948
2018
Q1
$1.5M Buy
+52,793
New +$1.5M ﹤0.01% 2796